Food-based Approach Development to Fulfil Amino Acid Gap by Considering the Intestinal Permeability of Children
The Role of Essential Amino Acid Intake and Intestinal Permeability on Amino Acid Blood Profile and Linear Growth Among Indonesian Children 12-24 Months Living in an Agricultural Area: A Basis for a Food Based Intervention
1 other identifier
observational
172
0 countries
N/A
Brief Summary
This study will be comprised of 2 phases. Phase 1 study is a comparative cross-sectional study which will be conducted among children aged 12-24 months living in agricultural area. A total of 172 healthy children consisted of 86 stunted children (Length for age z-score \<-2 Standard deviation) and 86 non-stunted children (Length for age z-score ≥0.5 Standard Deviation) will be recruited. Dietary intake, urine and dried blood spot from finger prick will be collected to assess amino acid intake, intestinal permeability and essential blood amino acid respectively. Qualitative study i.e. focus group discussion (FGD) and market survey will also be implemented. According to the result of phase 1 study, 2 types of food-based approaches will be developed, namely Complementary food recommendations (CFR) and Food multi-mix formula
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2019
CompletedFirst Posted
Study publicly available on registry
November 8, 2019
CompletedStudy Start
First participant enrolled
January 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedNovember 8, 2019
November 1, 2019
29 days
November 6, 2019
November 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Amino acid intake
Amino acid intake will be assessed by estimated food record
January - February 2020
Blood amino acid
Essential blood amino acid will be measured from finger prick dried blood spot and will be analyzed using LC-MS/MS
January - April 2020
Intestinal Permeability
Intestinal permeability will be measured from urine and will be analyzed using HPLC
January-April 2020
Other Outcomes (1)
Linear growth
December 2019
Study Arms (2)
Stunted Group
A comparative cross sectional study will compare stunted group and non-stunted group on amino acid intake, blood amino acid and intestinal permeability. Stunted group is defined as children who have LAZ \<-2 SD
Non-stunted Group
Non-stunted group will be those with LAZ \>= 0.5 SD matching by age and sex with stunted group. Other criteria will be similar. No Intervention will be given to the groups in this proposed protocol.
Eligibility Criteria
Target population of this study are children 12-24 months living in rural agricultural area in Kabupaten Malang. Kecamatan will be chosen based on the high prevalence of stunting and having potentials of protein food source to be optimized. Sample of the study are children living in selected villages in the period of 2019-2020 who fulfill the inclusion criteria.
You may qualify if:
- Stunting group is defined as length for age Z-score (LAZ) \<-2.0 SD and non-stunting group as LAZ ≥-0.5 SD
- Normal weight for length Z-score (WLZ ≥-2 SD to ≤+1 SD)
- Group matching by age, gender
- Singleton
- Full term gestation
- Normal birth weight
- Living with mother
- Not suffered from diarrhea at least in the last 1 month (as reported by the mothers)
- Not suffering from fever during assessment (as measured by the health staff)
- Not born from diabetic mothers (as reported by the mothers)
You may not qualify if:
- Drink Ultra High Temperature (UHT) milk at least 15 days before urine collection
- Taking any medication.
- Had taken non-steroidal anti-inflammatory drugs within two weeks of the study,
- Taken antibiotics within 4 weeks of the study,
- Unable to drink the sugar solution
- Refuse to participate until completion of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nia Novita Wirawanlead
- Indonesia Universitycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Badriul S Hegar, Prof
Indonesia University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 6, 2019
First Posted
November 8, 2019
Study Start
January 2, 2020
Primary Completion
January 31, 2020
Study Completion
April 30, 2020
Last Updated
November 8, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share
I will not share the IPD of the subject participated due to consent issue